Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Oct 17, 2022 9:35am
We need this
Man, the world needs a drug to combat symptoms and reduce spread...fingers crossed on BUC being the one! https://apple.news/Ar-DS_L-FS0ql2kVzXdCH8Q
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 16, 2022 8:11pm
Some Personal Thoughts on Recent Revive Developments !
#Bucillamine Thanks BobsterWat !! https://www.reddit.com/r/RVVTF/comments/y5ouow/some_personal_thoughts_on_recent_revive/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 15, 2022 9:31pm
BMT's comments re: Primary symptoms endpoint
#Bucillamine https://www.reddit.com/r/RVVTF/comments/y4r13p/primary_symptoms_endpoint/
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 15, 2022 8:19pm
PR firm that represents Pfizer and Moderna also sits on CDC
https://www.dailymail.co.uk/health/article-11303017/PR-firm-represents-Pfizer-Moderna-sits-CDC-vaccine-advisory-committee.htm
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Oct 14, 2022 5:26pm
When 3 pennies
https://nationalpost.com/health/canada-covid-19-drug-merck-independent-trial
(22)
•••
hk1966
X
View Profile
View Bullboard History
Comment by
hk1966
on Oct 14, 2022 4:18pm
RE:Fda loves to waste Canucks time
So true.. to borrow a phrase from Shaft 2000... "no malt liquor" ie. "no maple syrup aka no Canadians allowed"
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 14, 2022 2:15pm
Update looks good 👍
https://www.globenewswire.com/news-release/2022/10/14/2534882/0/en/Revive-Therapeutics-Announces-Finalization-of-Amended-Phase-3-COVID-19-Study-Protocol-to-FDA.html
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 14, 2022 1:54pm
$RVV $RVVTF - Update !
#Bucillamine https://finance.yahoo.com/news/revive-therapeutics-announces-finalization-amended-173400585.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 14, 2022 1:34pm
New Press Release - Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol to FDA
TORONTO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has...
read article.
(12)
•••
DehydraTECH
X
View Profile
View Bullboard History
Post by
DehydraTECH
on Oct 13, 2022 11:19pm
Fda loves to waste Canucks time
Going to be delay after delay And before you know it Michael Frank will be buying this stock at 3 cents again with a 10 to 1 reverse split
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 11, 2022 11:58am
LETS GO RVV!! 😀
https://ceo.ca/BUCILLAMINE
(36)
•••
WeedKing81
X
View Profile
View Bullboard History
Post by
WeedKing81
on Oct 11, 2022 11:57am
BUY THE DIPS AND HOLD. $$$
https://ceo.ca/BUCILLAMINE
(31)
•••
TheTerminator1
X
View Profile
View Bullboard History
Comment by
TheTerminator1
on Oct 09, 2022 7:34am
RE:Enjoy the long weekend ! Checkout these stocks, do UR DD !
Here is a guy who just finished loading up on a bunch of penny stocks...Pump away little man :)
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 08, 2022 11:30am
Enjoy the long weekend ! Checkout these stocks, do UR DD !
$EMO - TSX $BOMO - OTC $TONR - OTC $BYOC - OTC $ETEK - OTC GLTA !!!
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Oct 07, 2022 8:50pm
Hate W/Ends & Holidays until I become Rich $$$$$$ !
#Bucillamine
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?